Roles of Disulfide Bonds in Bacterial Alkaline Phosphatase*

(Received for publication, October 24, 1996)

Michio Sone , Satoshi Kishigami Dagger , Tohru Yoshihisa § and Koreaki Ito

From the Department of Cell Biology, Institute for Virus Research, Kyoto University, Kyoto 606-01, Japan

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Alkaline phosphatase of Escherichia coli (a homodimeric protein found in the periplasmic space) contains two intramolecular disulfide bonds (Cys-168-Cys-178 and Cys-286-Cys-336) that are formed after export to the periplasmic space. The location-specific folding character of this enzyme allowed its wide usage as a reporter of protein localization in prokaryotic cells. To study the roles of disulfide bonds in alkaline phosphatase, we eliminated each of them by Cys to Ser mutations. Intracellular stability of alkaline phosphatase decreased in the absence of either one or both of the disulfide bonds. The mutant proteins were stabilized in a DegP protease-deficient strain, allowing accumulation at significant levels and subsequent characterization. A mutant protein that lacked the N-terminally located disulfide bond (Cys-168-Cys-178) was found to have Cys-286 and Cys-336 residues disulfide-bonded, to have a dimeric structure, and to have almost full enzymatic activity. Nevertheless, the mutant protein lost the trypsin-resistant conformation that is characteristically observed for the wild-type enzyme. In contrast, mutants lacking Cys-286 and Cys-336 were monomeric and inactive. These results indicate that the Cys-286-Cys-336 disulfide bond is required and is sufficient for correctly positioning the active site region of this enzyme, but such an active conformation is still insufficient for the conformational stability of the enzyme. Thus, a fully active state of this enzyme can be formed without full protein stability, and the two disulfide bonds differentially contribute to these properties.


INTRODUCTION

Alkaline phosphatase (PhoA) is a periplasmic enzyme of Escherichia coli. It is a zinc- and magnesium-containing enzyme consisting of two identical subunits encoded by the phoA gene (1). Each of the subunits contains two intramolecular disulfide bridges, Cys-168-Cys-178 and Cys-286-Cys-336 (2). PhoA is initially synthesized as a precursor with an N-terminal 20-residue signal sequence that is removed during translocation across the cytoplasmic membrane. The mature 450-residue (or 449 when the N-terminal arginine residue is removed; Ref. 2) part of PhoA is then oxidized for its cysteine residues to form the disulfide bridges and is folded into a partially protease-resistant conformation (3). The subunit folding process is then followed by dimerization into the active metalloenzyme. This pathway of enzyme formation is completed within 2-3 min at 15 °C in the living cell (3).

The processes of folding/assembly of PhoA occur only after export to the periplasmic space (4-6). This property of PhoA has enabled its wide usage as a reporter of protein localization and membrane protein topology in prokaryotic cells (7, 8). The formation of disulfide bonds is a crucial event that triggers the correct folding of PhoA. In the cytoplasm, thioredoxin reductase and other factors seem to prevent disulfide bond formation on proteins (9). In the periplasm, the Dsb system facilitates disulfide bond formation (10, 11). It has been established that a periplasmic factor (DsbA) directly catalyzes oxidation of cysteines (12, 13). The membrane-bound factor DsbB is believed to reoxidize the reduced form of DsbA to allow it to function catalytically (14-16). Although biochemical studies on denaturation-renaturation as well as subunit association processes of PhoA were conducted previously (3, 17-22), and the structure of the enzyme was determined at a resolution of 2.8 Å (23) or 2.0 Å (24), the roles of the two disulfide bonds have not been precisely defined. In view of the importance of the disulfide bond formation for the formation of active PhoA enzyme, it is important to assign roles to each disulfide bond in the activity and stability of the enzyme. Thus, we have undertaken site-directed mutagenesis of cysteine residues of PhoA and examined the properties of the resulting mutant forms of the enzyme. The results show that the two disulfide bonds have different roles. Cys-286-Cys-336 was found to be required and was sufficient for the formation of the enzymatically active conformation, but was insufficient for supporting the protease-resistant structure, which proved to require Cys-168-Cys-178 as well. Thus, a fully active state of this enzyme can be formed without having the full stability of the protein.


EXPERIMENTAL PROCEDURES

Bacterial Strains

E. coli strains KS272 (Delta phoA) and KS474 (Delta phoA degP41::Tn5) were described by Strauch and Beckwith (25). Strains MS3 and MS5 were derivatives of KS272 and KS474, respectively, into which F'lacIQ lacPL8 lacZ+Y+A+ pro+ plasmid had been introduced from strain KI267 (26). Strains BW313 (27) and MV1184 (28) were used for site-directed mutagenesis.

Plasmids

pMS002 was a derivative of pBluescript-SK(-) carrying the phoA gene under the control of the lac promoter. It was constructed as follows. A polymerase chain reaction product was donated by N. Kusukawa of Takara Shuzo in which the phoA region of the chromosome was amplified using primers 5'GAAACAAAGCACTATTGC (starting at the third nucleotide of phoA) and 5'GTGATCTGCCATTAAGTC (starting at the 75th nucleotide after the end of the phoA reading frame). It was treated with the Klenow enzyme and cloned into the EcoRV site of pBluescript-SK(-). To eliminate any possible mutations introduced by polymerase chain reaction, a 1.4-kilobase pair BclI-KpnI fragment (representing most of the mature PhoA and some of the vector sequence) was replaced with the corresponding BclI-KpnI fragment that was prepared from a plasmid carrying the phoA gene of the confirmed sequence1 in which the phoA mature sequence had been similarly cloned at the EcoRV site of pT7Blue-Vector (Novagen). The remaining 5' part of the phoA sequence was confirmed by sequencing. In the resulting plasmid (pMS001), the initiation codon of phoA was recreated but was in the same frame as the lacZalpha sequence of the vector. Therefore, the PstI site at the upstream region was subjected to cleavage, filling-in by the Klenow enzyme and religation. The final product (pMS002) encodes the wild-type PhoA precursor.

Cys to Ser substitution mutations of PhoA were introduced into plasmid pMS002 by the procedures described by Kunkel (27), using the Muta-Gene Phagemid In Vitro Mutagenesis Kit (Bio-Rad). Synthetic oligonucleotides used as mutagenic primers were as follows: 5'GCGCAAA<UNL>TCC</UNL>TACGGTC3' for Cys-168 right-arrow Ser mutation, 5'AGTGAAAAA<UNL>TCT</UNL>CCGGGTA3' for Cys-178 right-arrow Ser mutation, 5'AGTCACC<UNL>TCT</UNL>ACGCCAA3' for Cys-286 right-arrow Ser mutation, and 5'GAATCCT<UNL>TCT</UNL>GGGCAAA3' for Cys-336 right-arrow Ser mutation (codons for Ser are underlined). Coding for PhoA(SCCC),2 pMS003 was first constructed using the Cys-168 right-arrow Ser primer. pMS004 (for PhoA(SSCC)), pMS006 (for PhoA(SSSC)), and pMS013 (for PhoA(SSCS)) were then constructed successively using appropriate primers. Similarly, pMS012 (for PhoA(CCSC)), pMS014 (for PhoA(CCCS)), and pMS015 (for PhoA(CCSS)) were constructed individually or in sequence. pMS016 (for PhoA(SSSS)) was constructed by replacing the EcoT14I-KpnI segment of pMS004 with that of pMS015. All the mutations were confirmed by sequencing.

Pulse-Chase and Immunoprecipitation

Cells were grown at 37 °C to an exponential phase in M9 medium (29) supplemented with 0.4% glycerol and 20 µg/ml each of amino acids, except methionine and cysteine. The phoA gene under the lac promoter control was induced with 1 mM isopropyl-beta -D-thiogalactoside. After 15 min, cells were pulse-labeled with 50 µCi/ml [35S]methionine (1100 Ci/mmol, obtained from American Radiolabeled Chemicals) followed by chase with unlabeled L-methionine (200 µg/ml) for indicated periods. A portion of the culture was treated with trichloroacetic acid, and protein precipitates were dissolved in SDS for subsequent immunoprecipitation as described previously (11). Anti-PhoA serum was purchased from 5 Prime right-arrow 3 Prime, Inc., Boulder, CO. Radioactive proteins were visualized and quantitated using a Bioimaging Analyzer BAS2000 (Fuji Film) in combination with a Discovery Series Densitometer (PDI).

Determination of PhoA Enzyme Activities

Cells of MS5 that carried a phoA plasmid were grown at 37 °C in L-broth containing 1 mM isopropyl-beta -D-thiogalactoside and 50 µg/ml ampicillin to an exponential phase (turbidity of 40 as measured by a Klett colorimeter with filter no. 54), mixed with a final concentration of 1 mM iodoacetamide, pelleted by centrifugation (placed in a microcentrifuge for 10 min), and resuspended in 1 M Tris-HCl (pH 8.1), 1 mM iodoacetamide (30). The procedures for the enzyme assay and unit definition were as described by Manoil and Beckwith (7). For assessing relative accumulation of PhoA proteins by immunoblotting, a portion of each culture was mixed directly with trichloroacetic acid (final concentration, 5%) to precipitate whole cell proteins that were solubilized in SDS-containing solution. Two fixed culture equivalents of samples (10 and 30 µl) were subjected to SDS-PAGE3 and immunoblotting using anti-PhoA serum, as described previously (31). PhoA activities of different mutant constructions were compared after normalizing the enzyme unit by relative accumulation levels of the PhoA proteins.

Sucrose Gradient Centrifugation and Native Gel Electrophoresis

To examine dimerization states of PhoA, cells of MS5 that carried a phoA plasmid were grown as described above, and the periplasmic fraction was prepared from 5 ml of culture as described previously (32). This fraction (480 µl) was layered on top of a 4.5-ml gradient of 5-20% sucrose in 10 mM Tris-HCl. After centrifugation at 45,000 rpm for 19 h in a Beckman SW65 rotor, the gradient was fractionated into 16 fractions that were then analyzed by 10% SDS-PAGE, followed by immunoblotting for distribution of PhoA proteins (3). Periplasmic fractions were also separated by gel electrophoresis without denaturation (33), and PhoA species were detected by immunoblotting.

Analysis of Intramolecular Disulfide Bonds by SDS-PAGE under Non-reducing Conditions

A 200-µl portion of a culture as described above was mixed with an equal volume of 10% trichloroacetic acid. Protein precipitates were washed with acetone and then dissolved in SDS/Tris-HCl/iodoacetamide solution (34). Samples were subjected to SDS-PAGE in the absence of any reducing reagent, followed by immunoblotting with anti-PhoA serum. In some experiments, the SDS solution used was slightly different (35), but the results were essentially not affected by this variation.

Trypsin Sensitivity Assay

Trypsin resistance of various PhoA constructions in crude cell lysates was assessed essentially as described previously (5, 31), except that iodoacetamide was included (30).

Purification of PhoA and PhoA(SSCC)

To overproduce these proteins, the phoA genes were cloned under the control of the ara promoter. pMS002 and pMS004 were linearized with KpnI and then partially digested with EcoRI. An approximately 1.5-kilobase fragment containing the phoA open reading frame was recovered and cloned into pBAD22 (36) that had been digested with EcoRI and KpnI. The resulting plasmids (named pMS019 and pMS021, respectively, for PhoA and PhoA(SSCC)) were introduced into strain MS5. Cells were cultivated in 4 liters of M9 amino acid medium described above (except containing 0.4% arabinose), and periplasmic fractions were prepared as described previously (32). PhoA proteins were purified according to the procedure of Chaidaroglou et al. (37). Approximately 10 and 0.5 mg of proteins of at least 90% purity (as judged from the SDS-PAGE profiles) were obtained for PhoA and PhoA(SSCC), respectively.


RESULTS AND DISCUSSION

Construction and Intracellular Stability of Cys to Ser Substitution Mutants of PhoA

The phoA gene, cloned under the control of the lac operator/promoter on a plasmid vector, was subjected to site-directed mutagenesis to construct a series of 8 mutants in which a Cys codon was converted into a Ser codon singly or in combination. For the sake of convenience, these mutant forms of PhoA are desginated by four-letter notations in which residues 168, 178, 286, and 336, are indicated by C (Cys) or S (Ser) in this order, respectively. Thus, for instance, PhoA(SSCC) indicates the PhoA mutant in which Cys residues at positions 168 and 178 have been replaced by Ser.

The mutant forms of PhoA were expressed in a Delta phoA strain. All of them were found to be unstable in vivo. Pulse-chase experiments showed that, in contrast to the wild-type PhoA protein (Fig. 1A), mutant forms were degraded after the synthesis (Fig. 1, B-D, closed symbols). The mutants that are not shown in Fig. 1 were similarly unstable. Their approximate half-lives were 5-10 min at 37 °C. They were significantly stabilized in the degP::Tn5 mutant strain (Fig. 1, B-D, open symbols). Although some proteolysis persisted even in the degP strain (Fig. 1), it was possible to accumulate mutant forms of PhoA using this periplasmic protease-deficient strain as a host.


Fig. 1. DegP-dependent degradation of mutant PhoA proteins. Cells were grown at 37 °C, induced with isopropyl-beta -D-thiogalactoside for the synthesis of PhoA proteins, and pulse-labeled with [35S]methionine for 0.5 min followed by chase with unlabeled methionine for the indicated periods. PhoA proteins were immunoprecipitated and subjected to SDS-PAGE. PhoA-associated radioactivities relative to those at the 1-min chase point are plotted for each construction that was expressed either in strain MS3 (degP+; closed squares) or strain MS5 (degP::Tn5; open circles). Plasmids carried were: A, pMS002 (PhoA(CCCC)); B, pMS004 (PhoA(SSCC)); C, pMS015 (PhoA(CCSS)); D, pMS003 (PhoA(SCCC)).
[View Larger Version of this Image (21K GIF file)]


The Cys-286-Cys-336 Disulfide Bond Is Essential, whereas the Cys-168-Cys-178 Disulfide Bond Is Dispensable for the PhoA Activity

The wild-type and mutant forms of PhoA were allowed to accumulate in the degP mutant cells, and their relative amounts were determined by subjecting whole cell extracts to SDS-PAGE and visualizing PhoA by immunoblotting. PhoA activities of the same cultures were assayed, and relative specific activities were determined by dividing the enzymatic activities by relative intensities of PhoA in the immunoblotting experiments (Table I). Only PhoA(SSCC) and PhoA(SCCC) were found to have significant enzyme activity (Table I). Since PhoA(CCSS), PhoA(CCCS), PhoA(CCSC), PhoA(SSSC), and PhoA(SSCS) were all inactive (see Table I for (CCSS); data not shown for the other mutants), the presence of both Cys-286 and Cys-336 was required for the activity. In contrast, Cys-168 and Cys-178 were dispensable for the enzymatic activity.

Table I.

Enzymatic activity of Cys/Ser mutants of PhoA


PhoA variant Cellular accumulation (relative value)a Activity Relative specific activityb Specific activity of purified proteinc

unit
(CCCC) (wild-type) 100 64 100 92
(SCCC) 58 8.4 23 ND
(SSCC) 86 54 98 94
(CCSS) 79 0 0 ND
(SSSS) 79 0 0 ND

a Determined by immunoblotting and quantitation of the stains by a Discovery Series Densitometer (PDI).
b The PhoA activity unit (7) was divided by the relative accumulation of the PhoA protein, and the value obtained was normalized by the wild-type value.
c Specific activity was indicated by the amount of p-nitrophenyl phosphate hydrolyzed (in µmol) per min/mg of protein at 25 °C and at pH 8.1. ND, not determined.

PhoA(SSCC) was as active as the wild-type enzyme (Table I), suggesting that Cys-286-Cys-336 is the sole activity-supporting disulfide bond in PhoA. To confirm this notion, PhoA and PhoA(SSCC) were overproduced and purified. Specific activities of these preparations were about the same (Table I). Interestingly, PhoA(SCCC), which contains an additional cysteine, was less active than PhoA(SSCC). We have evidence indicating that PhoA(SCCC) tends to form an aberrant disulfide bond.4

The Fully Active PhoA(SSCC) Forms a Dimer but Does Not Form the Protease-resistant Conformation

Normal PhoA sediments at about 6 S in sucrose gradient centrifugation, whereas an unfolded monomer subunit sediments at around 2 S (3, 19). Periplasmic fractions were fractionated by sucrose gradient centrifugation and examined for sedimentation behaviors of PhoA proteins (Fig. 2). It was found that enzymatically active PhoA(SSCC) sedimented to similar fractions as the wild-type enzyme (Fig. 2, compare A and B). In contrast, PhoA(CCSS) (which was inactive) sedimented much more slowly (Fig. 2C) to the position similar to that of PhoA(SSSS) (data not shown) or that of reduced and denatured PhoA (3). These results indicate that PhoA(SSCC), but not PhoA(CCSS), is competent for the dimer formation.


Fig. 2. Sedimentation profiles of PhoA variants with or without a particular disulfide bond. Periplasmic fractions were centrifuged through a 5-20% sucrose gradient as described under "Experimental Procedures." Distribution of PhoA proteins was examined by SDS-PAGE and immunoblotting with anti-PhoA serum. Strains used were: A, MS5/pMS002 (PhoA(CCCC)); B, MS5/pMS004 (PhoA(SSCC)); C, MS5/pMS015 (PhoA(CCSS)).
[View Larger Version of this Image (36K GIF file)]


The PhoA variants were also examined by PAGE at pH 8.8 under non-denaturing conditions. PhoA(SSCC) migrated to a similar position as the wild-type PhoA (Fig. 3, compare lanes 1 and 2). PhoA(CCSS) migrated much slower (Fig. 3, lane 3). PhoA(SSSS) also migrated slowly under the conditions used (data not shown). The basis for the slow migration of PhoA(CCSS) and PhoA(SSSS) is not known. It may be due to the lack of a compactly folded structure and/or different exposure of charged residues. In any case, the results of native PAGE are consistent with the notion that the overall structure of PhoA(SSCC) is similar to that of the wild-type enzyme.


Fig. 3. Native PAGE profiles of PhoA variants with or without a particular disulfide bond. Periplasmic fractions were subjected to PAGE at pH 8.8 under non-denaturing conditions. PhoA was detected by immunoblotting. Strains used were: lane 1, MS5/pMS002 (PhoA(CCCC)); lane 2, MS5/pMS004 (PhoA(SSCC)); lane 3, MS5/pMS015 (PhoA(CCSS)).
[View Larger Version of this Image (38K GIF file)]


To know whether the remaining cysteines in the mutant proteins are disulfide-bonded, we examined profiles of PhoA proteins in SDS-PAGE under non-reducing conditions. Normal PhoA with two disulfide bonds migrated faster than its reduced form (Fig. 4, compare lanes 1 and 2). Electrophoretic mobility of PhoA(SSCC) was indistinguishable from that of the oxidized wild-type enzyme (Fig. 4, compare lanes 3 and 4). After reduction with beta -mercaptoethanol, all the PhoA molecules shown in Fig. 4 migrated identically at the position of the reduced wild-type PhoA protein (data not shown). Thus, Cys-286 and Cys-336 that remain in PhoA(SSCC) form an intramolecular disulfide bond.


Fig. 4. Non-reducing SDS-PAGE profiles of PhoA variants with or without a particular disulfide bond. To assess the states of intramolecular disulfide bond formation, cells of MS5 (degP::Tn5) carrying a phoA plasmid as indicated below were analyzed by non-reducing SDS-PAGE, followed by immunoblotting with anti-PhoA serum. Plasmids carried were: lane 3, pMS002 (PhoA(CCCC)); lane 4, pMS004 (PhoA(SSCC); lane 5, pMS015 (PhoA(CCSS); lane 6, pMS016 (PhoA(SSSS). In lanes 1 and 2, purified E. coli alkaline phosphatase was treated in SDS sample buffer with (lane 1) or without (lane 2) beta -mercaptoethanol. Note that diffusion of beta -mercaptoethanol produced some reduced form of PhoA in lane 2. red and ox indicate the positions where the reduced or oxidized PhoA migrated, respectively.
[View Larger Version of this Image (49K GIF file)]


Electrophoretic mobility of PhoA(CCSS) (Fig. 4, lane 5) was indistinguishable from that of PhoA(SSSS) (Fig. 4, lane 6) or of reduced PhoA. Either Cys-168 and Cys-178 in this mutant remain reduced or the Cys-168-Cys-178 disulfide bond affects the electrophoretic mobility only negligibly. The close proximity of these residues in the primary sequence may suggest the latter possibility.

It was already shown in Fig. 1 that PhoA(SSCC) was unstable in vivo. Protease susceptibility of the mutant forms of PhoA was studied in vitro by trypsin digestion of cell extracts. Wild-type PhoA was resistant to up to 50 µg/ml trypsin examined (Fig. 5A, showing data for up to 10 µg/ml trypsin). PhoA(SSCC) was not resistant to even 2.5 µg/ml trypsin (Fig. 5B, lane 2). PhoA(CCSS) was not resistant to 5 µg/ml trypsin (Fig. 5C, lanes 2-5). These results show that the fully active and dimeric PhoA(SSCC) is still in loosely folded conformation.


Fig. 5. Trypsin sensitivities of PhoA variants with or without a particular disulfide bond. Cells of strain MS5 (degP::Tn5) carrying pMS002 (A, PhoA(CCCC)), pMS004 (B, PhoA(SSCC)), pMS015 (C, PhoA(CCSS)), or pMS016 (D, PhoA(SSSS)) were disrupted by lysozyme-freezing/thawing and then treated with trypsin of the indicated concentrations (µg/ml) at 0 °C for 30 min. Samples were then analyzed by SDS-PAGE and immunoblotting.
[View Larger Version of this Image (62K GIF file)]


Roles of Disulfide Bonds in Activity and Stability of Alkaline Phosphatase

The results presented above indicate that of the two disulfide bonds in PhoA, the one between Cys-286 and Cys-336 is sufficient for the enzymatic activity. However, it is not sufficient to confer the protease-resistant conformation normally observed for this enzyme. The other disulfide bond (between Cys-168 and Cys-178) is important for stabilization of the protein.

PhoA is one of the enzymes that exhibit a high degree of thermal stability and protease resistance (38). Intramolecular disulfide bond formation is a prerequisite for its folding into an active dimer (3). PhoA has been widely used as a reporter of protein export from the cytosol (7, 8). The reducing environment of the cytosol prevents folding and activation of PhoA, and thioredoxin reductase plays a key role in this prevention (6, 9). In contrast, the periplasmic space contains DsbA, which facilitates oxidative folding of newly synthesized proteins (10, 11). PhoA molecules that are internalized because of a defect in signal sequence as well as those exported to the periplasm of a dsbA-defective mutant strain lack enzymatic activity and are degraded by cellular or exogenous proteases (4-6, 10, 11). Our results now show directly that only one of the disulfide bonds (Cys-286-Cys-336) is essential for enzymatically active conformation of PhoA.

The active site of this enzyme contains two atoms of zinc and one of magnesium and involves at least the following amino acid residues: Asp-51, Ser-102, Asp-153, Thr-155, Arg-166, Glu-322, Asp-327, Lys-328, His-331, His-372, and His-412 (23, 24, 39). The Cys-286-Cys-336 disulfide bond, which connects two different loops that originate from different beta -strands, will constrain the central beta -sheet (with 10 strands) so that the active site residues are arranged in proper geometric configuration (24). In contrast, the conformational constraint imposed by the Cys-168-Cys-178 disulfide bond is limited within a single loop. Such a restriction may be trivial with respect to the formation of an active site and dimerization, but should be important for establishing a tight overall or local folding state that is crucial for the resistance of this enzyme to the action of proteases.

The finding that the Cys-168-Cys-178 disulfide bond is required for the tight folding without a major contribution to the active site formation (Table I) may corroborate the proposal (40) that the acquisition of a catalytic ability of a protein is often made possible at the expense of stability of the protein. By making a disulfide bridge, the Cys-168 and Cys-178 residues may have evolved to overcome such an intrinsic incompatibility between activity and stability of the enzyme. Subramaniam et al. (22) reported that during renaturation of guanidine hydrochloride-denatured PhoA, full enzymatic activity is achieved well before the establishment of the final conformation of the native enzyme. The PhoA(SSCC) molecule deserves structural studies.


FOOTNOTES

*   This work was supported by grants from the Ministry of Education, Science, and Culture, Japan, and from Mitsubishi Kasei Corp.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Present address: Laboratory for Cellular Information Processing, The Institute of Physical and Chemical Research, 2-1 Hirosawa, Wako, Saitama 351-01, Japan.
§   Present address: Laboratory of Biochemistry, Dept. of Chemistry, Graduate School of Science, Nagoya University, Nagoya 464-01, Japan.
   To whom correspondence should be addressed. Tel.: 81-75-751-4015; Fax: 81-75-771-5699 or 81-75-761-5626; E-mail: kito{at}virus.kyoto-u.ac.jp.
1   N. Kusukawa, unpublished data.
2   The four-letter notations, with C for cysteine and S for serine (in parentheses), indicate the amino acid residues 168, 178, 286, and 336, in that order.
3   The abbreviation used is: PAGE, polyacrylamide gel electrophoresis.
4   M. Sone, Y. Akiyama, and K. Ito, unpublished results.

Acknowledgments

We thank Yoshinori Akiyama for useful discussion, Noriko Kusukawa for the polymerase chain reaction product of the phoA gene, and Kiyoko Mochizuki and Kuniko Ueda for technical and secretarial support.


REFERENCES

  1. Chang, C. N., Kuang, W.-J., and Chen, E. Y. (1986) Gene (Amst.) 44, 121-125 [CrossRef][Medline] [Order article via Infotrieve]
  2. Bradshaw, R. A., Cancedda, F., Ericsson, L. H., Neumann, P. E., Piccoli, S. P., Schlesinger, M. J., Shriefer, K., and Walsh, K. A. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 3473-3477 [Abstract]
  3. Akiyama, Y., and Ito, K. (1993) J. Biol. Chem. 268, 8146-8150 [Abstract/Free Full Text]
  4. Boyd, D., Willard, S., Guan, C.-D., Wright, W., and Beckwith, J. (1987) in Phosphate Metabolism and Cellular Regulation in Microorganisms (Torriani-Gorini, A., Rothman, F. G., Silver, S., Wright, A., and Yagil, E., eds), pp. 89-93, American Society for Microbiology Press, Washington, D. C.
  5. Akiyama, Y., and Ito, K. (1989) J. Biol. Chem. 264, 437-442 [Abstract/Free Full Text]
  6. Derman, A. I., and Beckwith, J. (1991) J. Bacteriol. 173, 7719-7722 [Medline] [Order article via Infotrieve]
  7. Manoil, C., and Beckwith, J. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 8129-8133 [Abstract]
  8. Manoil, C., Mekalanos, J. J., and Beckwith, J. (1990) J. Bacteriol. 172, 515-518 [Medline] [Order article via Infotrieve]
  9. Derman, A. I., Prinz, W. A., Belin, D., and Beckwith, J. (1993) Science 262, 1744-1747 [Medline] [Order article via Infotrieve]
  10. Bardwell, J. C. A., McGovern, K., and Beckwith, J. (1991) Cell 67, 581-589 [Medline] [Order article via Infotrieve]
  11. Kamitani, S., Akiyama, Y., and Ito, K. (1992) EMBO J. 11, 57-62 [Abstract]
  12. Akiyama, Y., Kamitani, S., Kusukawa, N., and Ito, K. (1992) J. Biol. Chem. 267, 22440-22445 [Abstract/Free Full Text]
  13. Zapun, A., and Creighton, T. E. (1994) Biochemistry 33, 5202-5211 [Medline] [Order article via Infotrieve]
  14. Bardwell, J. C. A., Lee, J., Jander, G., Martin, N., Belin, D., and Beckwith, J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1038-1042 [Abstract]
  15. Kishigami, S., Kanaya, E., Kikuchi, M., and Ito, K. (1995) J. Biol. Chem. 270, 17072-17074 [Abstract/Free Full Text]
  16. Kishigami, S., and Ito, K. (1996) Genes Cells 1, 201-208 [Abstract/Free Full Text]
  17. Schlesinger, M. J., and Barrett, K. (1965) J. Biol. Chem. 240, 4284-4292 [Free Full Text]
  18. Schlesinger, M. J. (1965) J. Biol. Chem. 240, 4293-4298 [Free Full Text]
  19. Reynolds, J. A., and Schlesinger, M. J. (1967) Biochemistry 6, 3552-3559 [Medline] [Order article via Infotrieve]
  20. Applebury, M. L., and Coleman, J. E. (1969) J. Biol. Chem. 244, 308-318 [Abstract/Free Full Text]
  21. Falk, M. C., Bethune, J. L., and Vallee, B. L. (1982) Biochemistry 21, 1471-1478 [Medline] [Order article via Infotrieve]
  22. Subramaniam, V., Bergenhem, N. C. H., Gafni, A., and Steel, D. G. (1995) Biochemistry 34, 1133-1136 [Medline] [Order article via Infotrieve]
  23. Sowadski, J. M., Hanfdschumacher, M. D., Murthy, H. M. K., Foster, B. A., and Wyckoff, H. W. (1985) J. Mol. Biol. 186, 417-433 [Medline] [Order article via Infotrieve]
  24. Kim, E. E., and Wyckoff, H. W. (1991) J. Mol. Biol. 218, 449-464 [Medline] [Order article via Infotrieve]
  25. Strauch, K. L., and Beckwith, J. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 1576-1580 [Abstract]
  26. Shimoike, T., Taura, T., Kihara, A., Yoshihisa, T., Akiyama, Y., Cannon, K., and Ito, K. (1995) J. Biol. Chem. 270, 5519-5526 [Abstract/Free Full Text]
  27. Kunkel, T. A. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 488-492 [Abstract]
  28. Messing, J., and Vieira, J. (1987) Methods Enzymol. 153, 3-11 [Medline] [Order article via Infotrieve]
  29. Miller, J. H. (1972) Experiments in Molecular Genetics, p. 431, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  30. Derman, A. I., and Beckwith, J. (1995) J. Bacteriol. 177, 3764-3770 [Abstract]
  31. Akiyama, Y., Ogura, T., and Ito, K. (1994) J. Biol. Chem. 269, 5218-5224 [Abstract/Free Full Text]
  32. Ueguchi, C., and Ito, K. (1990) J. Bacteriol. 172, 5643-5649 [Medline] [Order article via Infotrieve]
  33. Bollag, D. M., and Edelstein, S. J. (1991) Protein Methods, pp. 143-160, Wiley-Liss, New York
  34. Pollitt, S., and Zalkin, H. (1983) J. Bacteriol. 153, 27-32 [Medline] [Order article via Infotrieve]
  35. Kishigami, S., Akiyama, Y., and Ito, K. (1995) FEBS Lett. 364, 55-58 [CrossRef][Medline] [Order article via Infotrieve]
  36. Guzman, L., Belin, D., Carson, M. J., and Beckwith, J. (1995) J. Bacteriol. 177, 4121-4130 [Abstract]
  37. Chaidaroglou, A., Bvezinski, D. J., Middleton, S. A., and Kantrowitz, E. R. (1988) Biochemistry 27, 8338-8343 [Medline] [Order article via Infotrieve]
  38. Torriani, A. (1968) Methods Enzymol. 12, 212-218 [CrossRef]
  39. Murphy, J. E., and Kantrowitz, E. R. (1994) Mol. Microbiol. 12, 351-357 [Medline] [Order article via Infotrieve]
  40. Shoichet, B. K., Baase, W. A., Kuroki, R., and Matthews, B. W. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 452-456 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.